Raizel M. Frasier

Raizel M. Frasier

Auto-generated profile, based on publicly available information

Raizel M. Frasier

Department of Psychiatry, Indiana University School of Medicine (IUSM), Indianapolis, IN, USA; Medical Scientist Training Program (MedNeuro), IUSM, Indianapolis, IN, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
MHMichael X. Henderson
Michael X. Henderson
ECEli J. Cornblath
Eli J. Cornblath
ADAdam Darwich
Adam Darwich
BZBin Zhang
Bin Zhang
HBHannah Brown
Hannah Brown
VLVirginia M. Y. Lee
Virginia M. Y. Lee

1 August 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RKRichard J. Karpowicz
Richard J. Karpowicz
CHConor M. Haney
Conor M. Haney
TMTiberiu S. Mihaila
Tiberiu S. Mihaila
RSRaizel M. Sandler
Raizel M. Sandler
EPE. James Petersson
E. James Petersson
VLVirginia M.-Y. Lee
Virginia M.-Y. Lee
Direct cell-to-cell transmission of proteopathic α-synuclein (α-syn) aggregates is thought to underlie the progression of neurodegenerative synucleinopathies. However, the specific intracellular processes governing this transmission remain unclear because currently available model systems are limited. For example, in cell culture models of α-syn-seeded aggregation, it is difficult to discern intracellular from extracellular exogenously applied α-syn seed species. Herein, we employed fluorescently labeled α-syn preformed fibrils (pffs) in conjunction with the membrane-impermeable fluorescence quencher trypan blue to selectively image internalized α-syn seeds in cultured primary neurons and to quantitatively characterize the concentration dependence, time course, and inhibition of pff uptake. To study the long-term fates of exogenous α-syn pffs in neurons, we developed a pff species labeled at amino acid residue 114 with the environmentally insensitive fluorophore BODIPY or the pH-sensitive dye pHrodo red. We found that pffs are rapidly trafficked along the endolysosomal pathway, where most of the material remains for days. We also found that brief pharmacological perturbation of lysosomes shortly after the pff treatment causes aberrations in intracellular processing of pff seeds concomitant with an increased rate of inclusion formation via recruitment of endogenous α-syn to a relatively small number of exogenous seeds. Our results validate a quantitative assay for pff uptake in primary neurons, implicate lysosomal processing as the major fate of internalized proteopathic seeds, and suggest lysosomal integrity as a significant rate-determining step in the transmission of α-syn pathology. Further, lysosomal processing of transmitted seeds may represent a new therapeutic target to combat the spread of synucleinopathies.

Verified
Journal Article
Open access
PDF file
Anna RadkeAnna Radke
Anna Radke
ESElizabeth Sneddon
Elizabeth Sneddon
RFRaizel M. Frasier
Raizel M. Frasier
FHFrederic W. Hopf
Frederic W. Hopf
Alcohol use disorder remains a substantial social, health, and economic problem and problem drinking levels in women have been increasing in recent years. Understanding whether and how the underlying mechanisms that drive drinking vary by sex is critical and could provide novel, more targeted therapeutic treatments. Here, we examine recent results from our laboratories and others which we believe provide useful insights into similarities and differences in alcohol drinking patterns across the sexes. Findings for binge intake and aversion-resistant, compulsion-like alcohol drinking are considered, since both are likely significant contributors to alcohol problems in humans. We also describe studies regarding mechanisms that may underlie sex differences in maladaptive alcohol drinking, with some focus on the importance of nucleus accumbens (NAcb) core and shell regions, several receptor types (dopamine, orexin, AMPA-type glutamate), and possible contributions of sex hormones. Finally, we discuss how stressors such as early life stress and anxiety-like states may interact with sex differences to contribute to alcohol drinking. Together, these findings underscore the importance and critical relevance of studying female and male mechanisms for alcohol and co-morbid conditions to gain a true and clinically useful understanding of addiction and neuropsychiatric mechanisms and treatment.

1 March 2020 in Neurobiology of Disease
Verified
Journal Article
Open access
MHMichael X. Henderson
Michael X. Henderson
DCDustin J. Covell
Dustin J. Covell
CCCharlotte Hiu-Yan Chung
Charlotte Hiu-Yan Chung
RPRose M. Pitkin
Rose M. Pitkin
RSRaizel M. Sandler
Raizel M. Sandler
KLKelvin C. Luk
Kelvin C. Luk
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are progressive neurodegenerative diseases for which there is no disease-modifying treatment. PD and DLB are characterized by aggregation of the synaptic protein α-synuclein, and there is compelling evidence to suggest that progression of these diseases is associated with the trans-cellular spread of pathogenic α-synuclein through the brains of afflicted individuals. Therapies targeting extracellular, pathogenic α-synuclein may therefore hold promise for slowing or halting disease progression. In this regard, it has been suggested that highly-selective antibodies can be administered as therapeutic agents targeting pathogenic proteins. In the current study, we screened a series of antibodies using multiple selection criterion to identify those that selectively bind pathogenic α-synuclein and show potent inhibition of pathology seeding in a neuronal model of α-synucleinopathy. A lead antibody was tested in a mouse model of PD, and it was able to reduce the spread of α-synuclein pathology in the brain and attenuate dopamine reductions in the striatum. This study highlights the therapeutic potential of α-synuclein immunotherapy for the treatment of PD and DLB, and provides a framework for screening of α-synuclein antibodies to identify those with preferred properties.

19 March 2024 in Addiction Biology
Verified
Journal Article
Open access
RFRaizel M. Frasier
Raizel M. Frasier
PSPhillip A. Starski
Phillip A. Starski
TSThatiane de Oliveira Sergio
Thatiane de Oliveira Sergio
AGAngela J. Grippo
Angela J. Grippo
FHFrederic W. Hopf
Frederic W. Hopf
Problem alcohol drinking continues to be a substantial cost and burden. In addition, alcohol consumption in women has increased in recent decades, and women can have greater alcohol problems and comorbidities. Thus, there is a significant need for novel therapeutics to enhance sex‐specific, individualized treatment. Heart rate (HR) and HR variability (HRV) are of broad interest because they may be both biomarkers for and drivers of pathological states. HRV reflects the dynamic balance between sympathetic (SNS, ‘fight or flight’) and parasympathetic (PNS, ‘rest and digest’) systems. Evidence from human studies suggest PNS predominance in women and SNS in men during autonomic regulation, indicating the possibility of sex differences in risk factors and physiological drivers of problem drinking. To better understand the association between HRV sex differences and alcohol drinking, we examined whether alcohol consumption levels correlated with time domain HRV measures (SDNN and rMSSD) at baseline, at alcohol drinking onset, and across 10 min of drinking, in adult female and male Wistar rats. In particular, we compared both HRV and HR measures under alcohol‐only and compulsion‐like conditions (alcohol + 10 mg/L quinine), because compulsion can often be a significant barrier to treatment of alcohol misuse. Importantly, previous work supports the possibility that different HRV measures could be interpreted to reflect PNS versus SNS influences. Here, we show that females with higher putative PNS indicators at baseline and at drinking onset had greater alcohol consumption. In contrast, male intake levels related to increased potential SNS measures at drinking onset. Once alcohol was consumed, HR predicted intake level in females, perhaps a pharmacological effect of alcohol. However, HRV changes were greater during compulsion‐like intake versus alcohol‐only, suggesting HRV changes (reduced SNS in females, reduced PNS and increased HR in males) specifically related to aversion‐resistant intake. We find novel and likely clinically relevant autonomic differences associated with biological sex and alcohol drinking, suggesting that different autonomic mechanisms may promote differing aspects of female and male alcohol consumption.

22 May 2026 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TSThatiane De Oliveira Sergio
Thatiane De Oliveira Sergio
RFRaizel M. Frasier
Raizel M. Frasier
SWSarah E. Wean
Sarah E. Wean
PSPhillip A. Starski
Phillip A. Starski
AZAlecsander W. Zareb
Alecsander W. Zareb
FHFrederic W. Hopf
Frederic W. Hopf
Alcohol Use Disorder remains a major challenge and is now a leading cause of death in adults. Biomarkers like heart rate variability (HRV) could give important and novel insights into how pharmacotherapies counteract excessive drive for alcohol, including those promoted by adrenergic receptors (AR). Indeed, α1AR inhibition helps heavy drinkers with greater withdrawal-related mood disruption and arousal, while α1ARs more generally are implicated in cognitive flexibility. To uncover how α1ARs might regulate drinking-related arousal, we used cardiovascular telemetry in adult male and female rats. In particular, we examined how HRV patterns were altered by lower doses of α1AR or βAR antagonists, which reveal arousal regulation with less behavioral disruption. Interestingly, HRV entropy has also been linked to cognitive flexibility, and we newly show that α1ARs supported HRV entropy in both sexes. However, in males but not females, α1ARs promoted pNN50, a parasympathetic metric indexing high variability in heartbeat timing. On the other hand, α1ARs with βARs in both sexes promoted a pro-sympathetic influence centered on a Power-law/fractal HRV metric previously linked to attentional effort, while α1ARs inhibited HF-HRV, a related parasympathetic metric, in females. Thus, α1ARs regulated multiple differing HRV arousal metrics, with both sympathetic and parasympathetic influences and sex similarities and differences. This was strongly different from the sex-similar pro-sympathetic βARs effects. Thus, our findings suggest that α1ARs are critical for multiple, differing aspects of physiological flexibility, which likely facilitates α1AR-mediated cognitive flexibility and the many other α1AR-regulated behaviors.